SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

ZATELLI, Maria Chiara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.499
EU - Europa 5.433
AS - Asia 4.949
SA - Sud America 428
AF - Africa 47
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 7
Totale 28.373
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.433
SG - Singapore 2.219
CN - Cina 1.798
DE - Germania 1.499
UA - Ucraina 1.127
IT - Italia 1.006
TR - Turchia 621
GB - Regno Unito 497
BR - Brasile 397
FI - Finlandia 360
SE - Svezia 266
PL - Polonia 203
RU - Federazione Russa 166
ID - Indonesia 134
NL - Olanda 66
FR - Francia 60
BE - Belgio 51
CA - Canada 51
HK - Hong Kong 50
AT - Austria 39
ZA - Sudafrica 20
LT - Lituania 17
VN - Vietnam 17
IQ - Iraq 15
MA - Marocco 11
PK - Pakistan 11
CZ - Repubblica Ceca 10
EU - Europa 10
IN - India 10
AR - Argentina 9
BD - Bangladesh 9
IE - Irlanda 9
MX - Messico 9
IR - Iran 8
JP - Giappone 8
CH - Svizzera 7
DK - Danimarca 7
UZ - Uzbekistan 7
MY - Malesia 6
RO - Romania 6
AU - Australia 5
EC - Ecuador 5
ES - Italia 5
NP - Nepal 5
EG - Egitto 4
GR - Grecia 4
JO - Giordania 4
KE - Kenya 4
KR - Corea 4
LV - Lettonia 4
PT - Portogallo 4
VE - Venezuela 4
BO - Bolivia 3
CL - Cile 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
HU - Ungheria 3
KG - Kirghizistan 3
OM - Oman 3
PY - Paraguay 3
SY - Repubblica araba siriana 3
AL - Albania 2
BG - Bulgaria 2
BY - Bielorussia 2
CO - Colombia 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LU - Lussemburgo 2
NG - Nigeria 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
BH - Bahrain 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
IL - Israele 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
MK - Macedonia 1
NI - Nicaragua 1
PA - Panama 1
RS - Serbia 1
SI - Slovenia 1
TG - Togo 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
Totale 28.373
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.085
Fairfield 1.882
Chandler 1.487
Ashburn 1.399
Jacksonville 1.264
Houston 1.195
Santa Clara 1.061
Singapore 999
Ann Arbor 842
Seattle 737
Wilmington 706
Cambridge 626
Izmir 409
Nanjing 374
Beijing 330
Princeton 311
Addison 276
Ferrara 241
Warsaw 203
Milan 188
San Diego 182
Boardman 179
Shanghai 173
Jakarta 130
New York 120
Helsinki 119
Shenyang 119
Los Angeles 114
Nanchang 110
Dearborn 100
Bremen 92
Hebei 85
Changsha 66
Tianjin 59
London 58
Mountain View 56
Jiaxing 55
Falls Church 52
Jinan 51
Washington 50
Hong Kong 46
Brussels 44
Kunming 43
Bologna 41
Redwood City 38
Munich 37
Norwalk 35
Falkenstein 34
Guangzhou 33
Rome 33
Frankfurt am Main 32
Nuremberg 32
Tappahannock 29
Toronto 29
Orange 26
Ningbo 25
São Paulo 24
San Mateo 23
Auburn Hills 22
Des Moines 19
Indiana 19
The Dalles 19
Hangzhou 18
Zhengzhou 18
Leawood 17
Taizhou 17
Dong Ket 16
Hefei 16
Belo Horizonte 15
Vienna 15
Chicago 13
Lanzhou 11
Ottawa 11
Porto Alegre 11
Redmond 11
Rio de Janeiro 11
Augusta 10
Council Bluffs 10
Lappeenranta 10
Modena 10
Padova 10
Campinas 9
Changchun 9
North Bergen 8
Baghdad 7
Brno 7
Chengdu 7
Curitiba 7
Ferrara di Monte Baldo 7
Haikou 7
Monmouth Junction 7
Naples 7
Ardabil 6
Assago 6
Philadelphia 6
Sorocaba 6
Walnut 6
Yellow Springs 6
Brescia 5
Dallas 5
Totale 19.646
Salva come PNG Salva come JPEG
Nome #
SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma 344
Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds 251
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas 181
Igf-I influences everolimus activity in medullary thyroid carcinoma 177
Applicability of laparoscopic approach to the resection of large adrenal tumours: a retrospective cohort study on 200 patients 176
Recettori della somatostatina e carcinoma midollare della tiroide: prospettive future. 171
Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses 170
Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines 167
Role of Ultrasonographic/Clinical Profile, Cytology, and BRAF V600E Mutation Evaluation in Thyroid Nodule Screening for Malignancy: A Prospective Study 165
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism 161
Relevance of BRAF(V600E) Mutation Testing Versus RAS Point Mutations and RET/PTC Rearrangements Evaluation in the Diagnosis of Thyroid Cancer 160
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression. 159
Cyclin D1 levels are involved in the resistance to m-TOR inhibitors in human bronchial carcinoids 158
Increase in Peripheral CD3-CD56brightCD16- Natural Killer Cells in Hashimoto's Thyroiditis Associated with HHV-6 Infection 158
A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization 155
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids 153
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. 151
8th edition of the AJCC/TNM staging system of thyroid cancer: What to expect (ITCO#2) 151
Predictors of Pituitary Dysfunction in Patients Surviving Ischemic Stroke 150
Inhibition of epithelial growth factor receptor can play an important role in reducing cell growth and survival in adrenocortical tumors 148
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion. 147
Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory 147
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 144
Functional characterization of a new deletion in CDKN1B 5'-UTR region 142
Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines. 140
BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine needle aspiration biopsies. 140
X-linked acrogigantism syndrome: clinical profile and therapeutic responses 139
Involvement of PKCβ and PKCδ isoforms in TSH signaling pathway in thyroid cancer cell lines 138
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 138
Levels of p27 sensitize to dual PI3K/mTOR inhibition 135
Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR region 135
Characteristics of a nationwide cohort of patients presenting with isolated hypogonadotropic hypogonadism (IHH) 134
The cytotoxic effect of sunitinib on human bronchial carcinoid cell lines and primary cultures is counteracted by EGF and IGF-1 but not by VEGF 134
Epidermal growth factor pathway as a possible target in the medical therapy of bronchial carcinoids 134
Adrenal cavernous hemangioma: a case report 132
Magmas, a Novel Over-Expressed Gene in Pituitary Rat Cell Lines and in Human Pituitary Adenomas: A New Pituitary Biomarker? 132
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 131
VEGF autocrine secretion is enhanced by EGFR activation trough ERK1/2 phosphorylation in human adrenocortical carcinoma cell lines 131
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 129
Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto’s thyroiditis 129
Pituitary side effects of old and new drugs. 129
Should aip gene screening be recommended in family members of FIPA patients with R16H variant? 129
Unexpected activation of pituitary-adrenal axis in healthy young and elderly subjects during somatostatin infusion 128
Acromegaly secondary to an incidentally discovered growth-hormone-releasing hormone secreting bronchial carcinoid tumour associated to a pituitary incidentaloma 127
Cerebral aneurysm and acromegaly: a case report 127
Magmas, a Gene Newly Identified as Overexpressed in Human and Mouse ACTH-Secreting Pituitary Adenomas, Protects Pituitary Cells from Apoptotic Stimuli 127
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 127
In vitro testing of new somatostatin analogs on pituitary tumor cells 126
Rare diseases in clinical endocrinology: a taxonomic classification system. 126
The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells. 126
HHV-6A in vitro infection of thyrocytes and T cells alters the expression of miRNA associated to autoimmune thyroiditis 126
EGF and IGF1 affect sunitinib activity in BP-NEN: New putative targets beyond VEGFR? 126
RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease 126
BRAFV600E analysis on fine needle aspiration biopsy increases diagnostic accuracy for papillary thyroid cancer in clinically unsuspected nodules 125
Radio-guided selective compartment neck dissection improves staging in papillary thyroid carcinoma: a prospective study on 345 patients with a 3-year follow-up. 125
Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study. 125
mTOR, p70S6K, AKT and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 124
Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation 124
Growth hormone excess promotes breast cancer chemoresistance 124
N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis 124
Recettori della Somatostatina e Carcinoma Midollare della Tiroide: prospettive future. 122
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes. 122
Magmas, a novel over-expressed gene in Pituitary rat cell lines and in human pituitary adenomas: a new pituitary bio marker? 122
MTOR inhibitors response and mTOR pathway in pancreatic neuroendocrine tumors 122
Therapeutic concentrations of mitotane (o,p'-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model. 121
Runx2 mRNA Expression in the Tissue, Serum, and Circulating Non-Hematopoietic Cells of Patients with Thyroid Cancer 121
mTOR mediated IGF1 proliferative effects on a rat pituitary GH/PRL secreting pituitary adenoma cell line 121
An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro 120
Somatostatin receptor subtype 1 selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line. 119
Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame 119
Evaluation of the Role of BRAFV600E Somatic Mutation on Papillary Thyroid Cancer Disease Persistence: A Prospective Study 119
Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. 119
Growth Hormone Enhances Breast Cancer Chemoresistance by Inhibiting JNK-Mediated Apoptosis 117
Effects of two mTOR inhibitors on in-vitro models of GH-secreting pituitary adenomas 117
Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells 117
miR-15a and miR-16-1 down-regulation in pituitary adenomas 116
Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects 116
Acute administration of human galanin in normal subjects reduces the potentiating effect of pyridostigmine-induced cholinergic enhancement on release of norepinephrine and pancreatic polypeptide 115
Evaluation of bone markers and structure in subclinical Cushing’s syndrome 115
Utilization of luminescent technology to develop a kinase assay: Cdk4 as a model system 115
Molecular basis of pharmacological therapy in Cushing's disease. 115
Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines 115
null 114
null 113
Presenza di HHV-6 in campioni tiroidei di pazienti con malattie autoimmuni della tiroide 113
Conventional and Nuclear Medicine Imaging in Ectopic Cushing's Syndrome: A Systematic Review 112
Cushing in a Leaf: Endocrine Disruption From a Natural Remedy 112
Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 112
Response to Pitoia and Niepomniszcze Thyroid 112
MicroRNAs and possible role in pituitary adenoma 111
Somatostatin, but not somatostatin receptor subtypes 2 and 5 selective agonists, inhibits calcitonin secretion and gene expression in the human medullary thyroid carcinoma cell line, TT. 111
null 111
Evidence for androgen receptor gene expression and growth inhibitory effect of dihydrotestosterone on human adrenocortical cells 111
Deletion of exons 1-3 of the MEN1 gene in a large Italian family causes the loss of menin expression 111
Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone (GH)- releasing hormone function 110
Inhibitory effect of dihydrotestosterone on human thyroid cell growth 110
R171Q MEN1 polymorphism in patients presenting with hyperparathyroidism 110
Somatostatin receptor subtypes 2 and 5 differentially affect proliferation in vitro of the human medullary thyroid carcinoma cell line TT 109
Growth hormone induces chemoresistance in breast cancer cells 109
Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: a multicenter study 109
Totale 13.363
Salva come PNG Salva come JPEG
Categoria #
all - tutte 158.760
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 7.291
Totale 166.051
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020833 0 0 0 0 0 0 0 0 0 498 255 80
2020/20213.348 271 234 199 449 206 341 101 368 98 477 429 175
2021/20222.754 113 256 179 54 118 160 129 151 114 223 266 991
2022/20233.186 321 277 130 435 467 440 168 266 385 26 165 106
2023/20242.076 151 193 103 57 138 315 56 454 58 47 49 455
2024/20255.424 206 165 605 202 929 796 221 311 1.250 739 0 0
Totale 28.905